© 2021 MJH Life Sciences and AJMC. All rights reserved.
© 2021 MJH Life Sciences™ and Clinical Care Targeted Communications, LLC. All rights reserved.
June 16th 2021, 5:30pm
About one-third of patients prefer in-hospital administration, particularly if they are older or already make frequent visits to the hospital.
June 11th 2021, 7:15pm
Patients with ankylosing spondylitis taking secukinumab saw improvements in enthesitis, and some achieved complete resolution, suggesting the drug could be a viable option for patients intolerant of or unresponsive to other enthesitis-improving medications.
June 5th 2021, 2:00am
The studies used population-level data from a county in Minnesota that has served as a national laboratory for health research since the 1960s.
May 29th 2021, 3:00pm
Using a large US database, researchers characterized the impact of psoriatic arthritis (PsA) in patients with disease activity in multiple domains vs those with disease activity affecting a single area.
May 26th 2021, 7:20pm
Methotrexate reduces cardiovascular risk in patients with inflammatory disease but not in the general population.
May 22nd 2021, 11:45am
Birth control guidance provided to women taking rheumatoid arthritis therapies is lacking, and other rheumatology news reported across MJH Life Sciences™.
May 22nd 2021, 12:00am
Ultrasounds and MRI are both used to monitor inflammation activity in rheumatoid arthritis, but their value in refining future treatment strategies has so far been unknown.
May 15th 2021, 9:15pm
Some of the latest rheumatology news includes updates on pregnancy, exercise, and treatment for psoriatic arthritis.
May 14th 2021, 8:21pm
Ankylosing spondylitis (AS) patients face a greater risk of mortality, but treatment with tumor necrosis factor inhibitors erases it.
May 8th 2021, 11:20am
Using acitretin in combination with secukinumab resulted in nearly complete or total relief for 3 patients with severe psoriasis, according to a case study.